Psychemedics (PMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,805 | 2,980 | 3,489 | 2,614 | 1,527 |
| Depreciation Amortization | 872 | 587 | 370 | 285 | 337 |
| Income taxes - deferred | 417 | 438 | 407 | 218 | 130 |
| Accounts receivable | 252 | -130 | -585 | -890 | 382 |
| Accounts payable and accrued liabilities | -159 | -292 | 262 | 519 | -464 |
| Other Working Capital | 319 | -1,376 | -749 | -216 | 65 |
| Other Operating Activity | 446 | 880 | 741 | 766 | 422 |
| Operating Cash Flow | $5,952 | $3,087 | $3,935 | $3,295 | $2,400 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,019 | -1,012 | -1,006 |
| PPE Investments | -1,532 | -2,214 | -1,359 | -818 | -35 |
| Purchase Of Investment | -226 | -121 | -131 | -30 | -15 |
| Investing Cash Flow | $-1,758 | $-2,335 | $529 | $-1,860 | $-1,056 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -110 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -22 | -6 | -79 |
| Dividend Paid | -3,179 | -3,157 | -2,511 | -2,500 | -3,014 |
| Other Financing Activity | 0 | -93 | -87 | -49 | -39 |
| Financing Cash Flow | $-3,289 | $-3,250 | $-2,620 | $-2,556 | $-3,133 |
| Beginning Cash Position | 3,066 | 5,564 | 3,721 | 4,840 | 6,630 |
| End Cash Position | 3,971 | 3,066 | 5,564 | 3,721 | 4,840 |
| Net Cash Flow | $905 | $-2,498 | $1,844 | $-1,120 | $-1,790 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,952 | 3,087 | 3,935 | 3,295 | 2,400 |
| Capital Expenditure | -1,532 | -2,214 | -1,359 | -818 | -35 |
| Free Cash Flow | 4,420 | 873 | 2,576 | 2,477 | 2,364 |